ROCK SPRINGS CAPITAL MANAGEMENT LP Alnylam Pharmaceuticals, Inc. Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$66.55M
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 18.05M $200.16 332.5K
Q2 2022 share 0.00% 0 shares -5.79M $145.85 332.5K
Q1 2022 share 0.00% 0 shares -2.09M $163.29 332.5K
Q4 2021 share Increase +6.91% 21.5K shares -2.33M $171.03 332.5K
Q3 2021 share Increase +3.67% 11K shares 7.86M $188.81 311K
Q2 2021 share 0.00% 0 shares 8.49M $169.52 300K
Q1 2021 share Decrease -10.45% -35K shares -1.18M $141.19 300K
Q4 2020 share Decrease -1.42% -4.81K shares -5.93M $129.97 335K
Q3 2020 share Decrease -1.50% -5.18K shares -1.62M $145.6 339.81K
Q2 2020 share Decrease -9.57% -36.5K shares 9.57M $148.11 345K
Q1 2020 share Increase +4.81% 17.5K shares -396K $108.85 381.5K
Q4 2019 share Increase +10.14% 33.5K shares 15.34M $115.17 364K
Q3 2019 share Increase +0.85% 2.8K shares 2.80M $80.42 330.5K
Q2 2019 share Increase +40.34% 94.2K shares 1.95M $72.56 327.7K
Q1 2019 share Increase +20.36% 39.5K shares 7.67M $93.45 233.5K
Q4 2018 share Decrease -1.27% -2.5K shares -3.05M $72.91 194K
Q3 2018 share Increase +13.26% 23K shares 110K $87.52 196.5K
Q2 2018 share Increase +21.33% 30.5K shares 57K $98.49 173.5K
Q1 2018 share Increase +10.00% 13K shares 514K $119.1 143K
Q4 2017 share Increase +23.81% 25K shares 4.18M $127.05 130K
Q3 2017 share 0.00% 0 shares 3.96M $117.49 105K
Q2 2017 share Increase 0.00% 105K shares 8.37M $79.76 105K